nodes	percent_of_prediction	percent_of_DWPC	metapath
Dantrolene—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.109	0.463	CbGbCtD
Dantrolene—CYP3A4—Progesterone—uterine cancer	0.0723	0.306	CbGbCtD
Dantrolene—CYP3A4—Etoposide—uterine cancer	0.0323	0.137	CbGbCtD
Dantrolene—RYR3—myometrium—uterine cancer	0.032	0.122	CbGeAlD
Dantrolene—RYR3—uterine cervix—uterine cancer	0.0249	0.0952	CbGeAlD
Dantrolene—RYR3—smooth muscle tissue—uterine cancer	0.0242	0.0926	CbGeAlD
Dantrolene—RYR1—myometrium—uterine cancer	0.023	0.0878	CbGeAlD
Dantrolene—RYR3—endometrium—uterine cancer	0.0225	0.0861	CbGeAlD
Dantrolene—CYP3A4—Doxorubicin—uterine cancer	0.0221	0.0935	CbGbCtD
Dantrolene—RYR3—uterus—uterine cancer	0.0208	0.0794	CbGeAlD
Dantrolene—RYR3—female reproductive system—uterine cancer	0.0187	0.0714	CbGeAlD
Dantrolene—RYR1—smooth muscle tissue—uterine cancer	0.0174	0.0664	CbGeAlD
Dantrolene—RYR3—vagina—uterine cancer	0.0169	0.0645	CbGeAlD
Dantrolene—RYR1—mammalian vulva—uterine cancer	0.0156	0.0598	CbGeAlD
Dantrolene—RYR1—uterus—uterine cancer	0.0149	0.0569	CbGeAlD
Dantrolene—RYR1—female reproductive system—uterine cancer	0.0134	0.0512	CbGeAlD
Dantrolene—RYR1—vagina—uterine cancer	0.0121	0.0463	CbGeAlD
Dantrolene—CYP3A4—renal system—uterine cancer	0.00291	0.0111	CbGeAlD
Dantrolene—CYP3A4—female reproductive system—uterine cancer	0.00233	0.0089	CbGeAlD
Dantrolene—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.00291	CcSEcCtD
Dantrolene—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.00146	0.0029	CcSEcCtD
Dantrolene—Dyspepsia—Progesterone—uterine cancer	0.00145	0.00288	CcSEcCtD
Dantrolene—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00144	0.00287	CcSEcCtD
Dantrolene—Lacrimation increased—Epirubicin—uterine cancer	0.00144	0.00286	CcSEcCtD
Dantrolene—Decreased appetite—Progesterone—uterine cancer	0.00143	0.00285	CcSEcCtD
Dantrolene—Nocturia—Epirubicin—uterine cancer	0.00143	0.00284	CcSEcCtD
Dantrolene—Erythema—Dactinomycin—uterine cancer	0.00143	0.00284	CcSEcCtD
Dantrolene—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.00142	0.00283	CcSEcCtD
Dantrolene—Fatigue—Progesterone—uterine cancer	0.00142	0.00282	CcSEcCtD
Dantrolene—Constipation—Progesterone—uterine cancer	0.00141	0.0028	CcSEcCtD
Dantrolene—Pain—Progesterone—uterine cancer	0.00141	0.0028	CcSEcCtD
Dantrolene—Extravasation—Doxorubicin—uterine cancer	0.0014	0.00279	CcSEcCtD
Dantrolene—Atrioventricular block—Epirubicin—uterine cancer	0.00136	0.00271	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.00136	0.0027	CcSEcCtD
Dantrolene—Feeling abnormal—Progesterone—uterine cancer	0.00136	0.0027	CcSEcCtD
Dantrolene—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.00135	0.00268	CcSEcCtD
Dantrolene—Gastrointestinal pain—Progesterone—uterine cancer	0.00135	0.00268	CcSEcCtD
Dantrolene—Lacrimation increased—Doxorubicin—uterine cancer	0.00133	0.00264	CcSEcCtD
Dantrolene—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.00133	0.00264	CcSEcCtD
Dantrolene—Ill-defined disorder—Dactinomycin—uterine cancer	0.00132	0.00263	CcSEcCtD
Dantrolene—Nocturia—Doxorubicin—uterine cancer	0.00132	0.00263	CcSEcCtD
Dantrolene—Anaemia—Dactinomycin—uterine cancer	0.00132	0.00262	CcSEcCtD
Dantrolene—Injection site reaction—Epirubicin—uterine cancer	0.00132	0.00262	CcSEcCtD
Dantrolene—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.00131	0.00261	CcSEcCtD
Dantrolene—Urticaria—Progesterone—uterine cancer	0.00131	0.0026	CcSEcCtD
Dantrolene—Abdominal pain—Progesterone—uterine cancer	0.0013	0.00259	CcSEcCtD
Dantrolene—Body temperature increased—Progesterone—uterine cancer	0.0013	0.00259	CcSEcCtD
Dantrolene—Renal failure—Etoposide—uterine cancer	0.0013	0.00258	CcSEcCtD
Dantrolene—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.0013	0.00258	CcSEcCtD
Dantrolene—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.00129	0.00256	CcSEcCtD
Dantrolene—Malaise—Dactinomycin—uterine cancer	0.00129	0.00256	CcSEcCtD
Dantrolene—Leukopenia—Dactinomycin—uterine cancer	0.00128	0.00254	CcSEcCtD
Dantrolene—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.00128	0.00254	CcSEcCtD
Dantrolene—Atrioventricular block—Doxorubicin—uterine cancer	0.00126	0.00251	CcSEcCtD
Dantrolene—Aplastic anaemia—Epirubicin—uterine cancer	0.00124	0.00247	CcSEcCtD
Dantrolene—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00123	0.00245	CcSEcCtD
Dantrolene—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00122	0.00243	CcSEcCtD
Dantrolene—Injection site reaction—Doxorubicin—uterine cancer	0.00122	0.00242	CcSEcCtD
Dantrolene—Myalgia—Dactinomycin—uterine cancer	0.00121	0.00242	CcSEcCtD
Dantrolene—Hypersensitivity—Progesterone—uterine cancer	0.00121	0.00241	CcSEcCtD
Dantrolene—Discomfort—Dactinomycin—uterine cancer	0.0012	0.00239	CcSEcCtD
Dantrolene—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.00119	0.00236	CcSEcCtD
Dantrolene—Asthenia—Progesterone—uterine cancer	0.00118	0.00235	CcSEcCtD
Dantrolene—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00235	CcSEcCtD
Dantrolene—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00118	0.00235	CcSEcCtD
Dantrolene—Pulmonary oedema—Epirubicin—uterine cancer	0.00118	0.00234	CcSEcCtD
Dantrolene—Pruritus—Progesterone—uterine cancer	0.00116	0.00232	CcSEcCtD
Dantrolene—Aplastic anaemia—Doxorubicin—uterine cancer	0.00115	0.00229	CcSEcCtD
Dantrolene—Thrombocytopenia—Dactinomycin—uterine cancer	0.00114	0.00227	CcSEcCtD
Dantrolene—Diarrhoea—Progesterone—uterine cancer	0.00113	0.00224	CcSEcCtD
Dantrolene—Phlebitis—Epirubicin—uterine cancer	0.00112	0.00222	CcSEcCtD
Dantrolene—Thrombophlebitis—Epirubicin—uterine cancer	0.00111	0.00221	CcSEcCtD
Dantrolene—Anorexia—Dactinomycin—uterine cancer	0.00111	0.00221	CcSEcCtD
Dantrolene—Flushing—Etoposide—uterine cancer	0.0011	0.00219	CcSEcCtD
Dantrolene—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.00219	CcSEcCtD
Dantrolene—Pulmonary oedema—Doxorubicin—uterine cancer	0.00109	0.00217	CcSEcCtD
Dantrolene—Dizziness—Progesterone—uterine cancer	0.00109	0.00217	CcSEcCtD
Dantrolene—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.00107	0.00213	CcSEcCtD
Dantrolene—Hepatic failure—Epirubicin—uterine cancer	0.00107	0.00213	CcSEcCtD
Dantrolene—Chills—Etoposide—uterine cancer	0.00106	0.00212	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.00106	0.00211	CcSEcCtD
Dantrolene—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.00106	0.0021	CcSEcCtD
Dantrolene—Vomiting—Progesterone—uterine cancer	0.00105	0.00208	CcSEcCtD
Dantrolene—Rash—Progesterone—uterine cancer	0.00104	0.00207	CcSEcCtD
Dantrolene—Dermatitis—Progesterone—uterine cancer	0.00104	0.00206	CcSEcCtD
Dantrolene—Phlebitis—Doxorubicin—uterine cancer	0.00103	0.00205	CcSEcCtD
Dantrolene—Headache—Progesterone—uterine cancer	0.00103	0.00205	CcSEcCtD
Dantrolene—Thrombophlebitis—Doxorubicin—uterine cancer	0.00103	0.00204	CcSEcCtD
Dantrolene—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00102	0.00203	CcSEcCtD
Dantrolene—Decreased appetite—Dactinomycin—uterine cancer	0.00101	0.00201	CcSEcCtD
Dantrolene—Dysgeusia—Etoposide—uterine cancer	0.00101	0.00201	CcSEcCtD
Dantrolene—Fatigue—Dactinomycin—uterine cancer	0.001	0.002	CcSEcCtD
Dantrolene—Back pain—Etoposide—uterine cancer	0.000998	0.00199	CcSEcCtD
Dantrolene—Pain—Dactinomycin—uterine cancer	0.000995	0.00198	CcSEcCtD
Dantrolene—Hepatic failure—Doxorubicin—uterine cancer	0.000989	0.00197	CcSEcCtD
Dantrolene—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000987	0.00196	CcSEcCtD
Dantrolene—Cardiac failure—Epirubicin—uterine cancer	0.000984	0.00196	CcSEcCtD
Dantrolene—Nausea—Progesterone—uterine cancer	0.000978	0.00195	CcSEcCtD
Dantrolene—Pain in extremity—Epirubicin—uterine cancer	0.000961	0.00191	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	0.000961	0.00191	CcSEcCtD
Dantrolene—Diplopia—Epirubicin—uterine cancer	0.000961	0.00191	CcSEcCtD
Dantrolene—Feeling abnormal—Dactinomycin—uterine cancer	0.000959	0.00191	CcSEcCtD
Dantrolene—Ill-defined disorder—Etoposide—uterine cancer	0.000958	0.00191	CcSEcCtD
Dantrolene—Anaemia—Etoposide—uterine cancer	0.000954	0.0019	CcSEcCtD
Dantrolene—Gastrointestinal pain—Dactinomycin—uterine cancer	0.000952	0.00189	CcSEcCtD
Dantrolene—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000949	0.00189	CcSEcCtD
Dantrolene—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000941	0.00187	CcSEcCtD
Dantrolene—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00094	0.00187	CcSEcCtD
Dantrolene—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000935	0.00186	CcSEcCtD
Dantrolene—Malaise—Etoposide—uterine cancer	0.000931	0.00185	CcSEcCtD
Dantrolene—Leukopenia—Etoposide—uterine cancer	0.000924	0.00184	CcSEcCtD
Dantrolene—Abdominal pain—Dactinomycin—uterine cancer	0.00092	0.00183	CcSEcCtD
Dantrolene—Body temperature increased—Dactinomycin—uterine cancer	0.00092	0.00183	CcSEcCtD
Dantrolene—Cardiac failure—Doxorubicin—uterine cancer	0.000911	0.00181	CcSEcCtD
Dantrolene—Convulsion—Etoposide—uterine cancer	0.000894	0.00178	CcSEcCtD
Dantrolene—Hypertension—Etoposide—uterine cancer	0.000891	0.00177	CcSEcCtD
Dantrolene—Pain in extremity—Doxorubicin—uterine cancer	0.000889	0.00177	CcSEcCtD
Dantrolene—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	0.000889	0.00177	CcSEcCtD
Dantrolene—Diplopia—Doxorubicin—uterine cancer	0.000889	0.00177	CcSEcCtD
Dantrolene—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000886	0.00176	CcSEcCtD
Dantrolene—Discomfort—Etoposide—uterine cancer	0.000868	0.00173	CcSEcCtD
Dantrolene—Hypersensitivity—Dactinomycin—uterine cancer	0.000857	0.00171	CcSEcCtD
Dantrolene—Confusional state—Etoposide—uterine cancer	0.000849	0.00169	CcSEcCtD
Dantrolene—Muscular weakness—Epirubicin—uterine cancer	0.000847	0.00169	CcSEcCtD
Dantrolene—Anaphylactic shock—Etoposide—uterine cancer	0.000842	0.00168	CcSEcCtD
Dantrolene—Asthenia—Dactinomycin—uterine cancer	0.000835	0.00166	CcSEcCtD
Dantrolene—Dysphagia—Epirubicin—uterine cancer	0.00083	0.00165	CcSEcCtD
Dantrolene—Thrombocytopenia—Etoposide—uterine cancer	0.000825	0.00164	CcSEcCtD
Dantrolene—Tachycardia—Etoposide—uterine cancer	0.000822	0.00164	CcSEcCtD
Dantrolene—Eosinophilia—Epirubicin—uterine cancer	0.000822	0.00164	CcSEcCtD
Dantrolene—Hyperhidrosis—Etoposide—uterine cancer	0.000814	0.00162	CcSEcCtD
Dantrolene—Anorexia—Etoposide—uterine cancer	0.000803	0.0016	CcSEcCtD
Dantrolene—Diarrhoea—Dactinomycin—uterine cancer	0.000796	0.00158	CcSEcCtD
Dantrolene—Muscular weakness—Doxorubicin—uterine cancer	0.000784	0.00156	CcSEcCtD
Dantrolene—Dysphagia—Doxorubicin—uterine cancer	0.000768	0.00153	CcSEcCtD
Dantrolene—Pollakiuria—Epirubicin—uterine cancer	0.000767	0.00153	CcSEcCtD
Dantrolene—Eosinophilia—Doxorubicin—uterine cancer	0.000761	0.00151	CcSEcCtD
Dantrolene—Somnolence—Etoposide—uterine cancer	0.000749	0.00149	CcSEcCtD
Dantrolene—Drowsiness—Epirubicin—uterine cancer	0.00074	0.00147	CcSEcCtD
Dantrolene—Vomiting—Dactinomycin—uterine cancer	0.00074	0.00147	CcSEcCtD
Dantrolene—Rash—Dactinomycin—uterine cancer	0.000734	0.00146	CcSEcCtD
Dantrolene—Decreased appetite—Etoposide—uterine cancer	0.000732	0.00146	CcSEcCtD
Dantrolene—Renal failure—Epirubicin—uterine cancer	0.000728	0.00145	CcSEcCtD
Dantrolene—Fatigue—Etoposide—uterine cancer	0.000726	0.00144	CcSEcCtD
Dantrolene—Constipation—Etoposide—uterine cancer	0.00072	0.00143	CcSEcCtD
Dantrolene—Pain—Etoposide—uterine cancer	0.00072	0.00143	CcSEcCtD
Dantrolene—Sweating—Epirubicin—uterine cancer	0.00071	0.00141	CcSEcCtD
Dantrolene—Pollakiuria—Doxorubicin—uterine cancer	0.00071	0.00141	CcSEcCtD
Dantrolene—Haematuria—Epirubicin—uterine cancer	0.000706	0.0014	CcSEcCtD
Dantrolene—Feeling abnormal—Etoposide—uterine cancer	0.000694	0.00138	CcSEcCtD
Dantrolene—Nausea—Dactinomycin—uterine cancer	0.000691	0.00138	CcSEcCtD
Dantrolene—Gastrointestinal pain—Etoposide—uterine cancer	0.000689	0.00137	CcSEcCtD
Dantrolene—Drowsiness—Doxorubicin—uterine cancer	0.000685	0.00136	CcSEcCtD
Dantrolene—Renal failure—Doxorubicin—uterine cancer	0.000673	0.00134	CcSEcCtD
Dantrolene—Urticaria—Etoposide—uterine cancer	0.000669	0.00133	CcSEcCtD
Dantrolene—Haemoglobin—Epirubicin—uterine cancer	0.000668	0.00133	CcSEcCtD
Dantrolene—Abdominal pain—Etoposide—uterine cancer	0.000666	0.00132	CcSEcCtD
Dantrolene—Body temperature increased—Etoposide—uterine cancer	0.000666	0.00132	CcSEcCtD
Dantrolene—Hepatitis—Epirubicin—uterine cancer	0.000665	0.00132	CcSEcCtD
Dantrolene—Haemorrhage—Epirubicin—uterine cancer	0.000665	0.00132	CcSEcCtD
Dantrolene—Sweating—Doxorubicin—uterine cancer	0.000657	0.00131	CcSEcCtD
Dantrolene—Haematuria—Doxorubicin—uterine cancer	0.000653	0.0013	CcSEcCtD
Dantrolene—Visual impairment—Epirubicin—uterine cancer	0.00064	0.00127	CcSEcCtD
Dantrolene—Hypersensitivity—Etoposide—uterine cancer	0.000621	0.00123	CcSEcCtD
Dantrolene—Haemoglobin—Doxorubicin—uterine cancer	0.000618	0.00123	CcSEcCtD
Dantrolene—Flushing—Epirubicin—uterine cancer	0.000617	0.00123	CcSEcCtD
Dantrolene—Haemorrhage—Doxorubicin—uterine cancer	0.000615	0.00122	CcSEcCtD
Dantrolene—Hepatitis—Doxorubicin—uterine cancer	0.000615	0.00122	CcSEcCtD
Dantrolene—Asthenia—Etoposide—uterine cancer	0.000604	0.0012	CcSEcCtD
Dantrolene—Chills—Epirubicin—uterine cancer	0.000596	0.00119	CcSEcCtD
Dantrolene—Pruritus—Etoposide—uterine cancer	0.000596	0.00119	CcSEcCtD
Dantrolene—Visual impairment—Doxorubicin—uterine cancer	0.000593	0.00118	CcSEcCtD
Dantrolene—Erythema—Epirubicin—uterine cancer	0.000578	0.00115	CcSEcCtD
Dantrolene—Diarrhoea—Etoposide—uterine cancer	0.000576	0.00115	CcSEcCtD
Dantrolene—Flushing—Doxorubicin—uterine cancer	0.000571	0.00114	CcSEcCtD
Dantrolene—Tension—Epirubicin—uterine cancer	0.000568	0.00113	CcSEcCtD
Dantrolene—Dysgeusia—Epirubicin—uterine cancer	0.000567	0.00113	CcSEcCtD
Dantrolene—Nervousness—Epirubicin—uterine cancer	0.000562	0.00112	CcSEcCtD
Dantrolene—Back pain—Epirubicin—uterine cancer	0.00056	0.00111	CcSEcCtD
Dantrolene—Dizziness—Etoposide—uterine cancer	0.000557	0.00111	CcSEcCtD
Dantrolene—Chills—Doxorubicin—uterine cancer	0.000552	0.0011	CcSEcCtD
Dantrolene—Vision blurred—Epirubicin—uterine cancer	0.000545	0.00108	CcSEcCtD
Dantrolene—Ill-defined disorder—Epirubicin—uterine cancer	0.000537	0.00107	CcSEcCtD
Dantrolene—Vomiting—Etoposide—uterine cancer	0.000536	0.00107	CcSEcCtD
Dantrolene—Erythema—Doxorubicin—uterine cancer	0.000535	0.00107	CcSEcCtD
Dantrolene—Anaemia—Epirubicin—uterine cancer	0.000535	0.00106	CcSEcCtD
Dantrolene—Rash—Etoposide—uterine cancer	0.000531	0.00106	CcSEcCtD
Dantrolene—Dermatitis—Etoposide—uterine cancer	0.000531	0.00106	CcSEcCtD
Dantrolene—Headache—Etoposide—uterine cancer	0.000528	0.00105	CcSEcCtD
Dantrolene—Tension—Doxorubicin—uterine cancer	0.000525	0.00105	CcSEcCtD
Dantrolene—Dysgeusia—Doxorubicin—uterine cancer	0.000524	0.00104	CcSEcCtD
Dantrolene—Malaise—Epirubicin—uterine cancer	0.000522	0.00104	CcSEcCtD
Dantrolene—Nervousness—Doxorubicin—uterine cancer	0.00052	0.00103	CcSEcCtD
Dantrolene—Leukopenia—Epirubicin—uterine cancer	0.000518	0.00103	CcSEcCtD
Dantrolene—Back pain—Doxorubicin—uterine cancer	0.000518	0.00103	CcSEcCtD
Dantrolene—Vision blurred—Doxorubicin—uterine cancer	0.000504	0.001	CcSEcCtD
Dantrolene—Convulsion—Epirubicin—uterine cancer	0.000501	0.000997	CcSEcCtD
Dantrolene—Nausea—Etoposide—uterine cancer	0.0005	0.000995	CcSEcCtD
Dantrolene—Hypertension—Epirubicin—uterine cancer	0.000499	0.000994	CcSEcCtD
Dantrolene—Ill-defined disorder—Doxorubicin—uterine cancer	0.000497	0.000988	CcSEcCtD
Dantrolene—Anaemia—Doxorubicin—uterine cancer	0.000495	0.000984	CcSEcCtD
Dantrolene—Myalgia—Epirubicin—uterine cancer	0.000493	0.00098	CcSEcCtD
Dantrolene—Discomfort—Epirubicin—uterine cancer	0.000487	0.000968	CcSEcCtD
Dantrolene—Malaise—Doxorubicin—uterine cancer	0.000483	0.00096	CcSEcCtD
Dantrolene—Dry mouth—Epirubicin—uterine cancer	0.000482	0.000958	CcSEcCtD
Dantrolene—Leukopenia—Doxorubicin—uterine cancer	0.000479	0.000953	CcSEcCtD
Dantrolene—Confusional state—Epirubicin—uterine cancer	0.000476	0.000947	CcSEcCtD
Dantrolene—Anaphylactic shock—Epirubicin—uterine cancer	0.000472	0.000939	CcSEcCtD
Dantrolene—Convulsion—Doxorubicin—uterine cancer	0.000464	0.000923	CcSEcCtD
Dantrolene—Thrombocytopenia—Epirubicin—uterine cancer	0.000462	0.00092	CcSEcCtD
Dantrolene—Hypertension—Doxorubicin—uterine cancer	0.000462	0.00092	CcSEcCtD
Dantrolene—Tachycardia—Epirubicin—uterine cancer	0.000461	0.000917	CcSEcCtD
Dantrolene—Hyperhidrosis—Epirubicin—uterine cancer	0.000456	0.000908	CcSEcCtD
Dantrolene—Myalgia—Doxorubicin—uterine cancer	0.000456	0.000907	CcSEcCtD
Dantrolene—Discomfort—Doxorubicin—uterine cancer	0.00045	0.000896	CcSEcCtD
Dantrolene—Anorexia—Epirubicin—uterine cancer	0.00045	0.000895	CcSEcCtD
Dantrolene—Dry mouth—Doxorubicin—uterine cancer	0.000446	0.000887	CcSEcCtD
Dantrolene—Confusional state—Doxorubicin—uterine cancer	0.00044	0.000876	CcSEcCtD
Dantrolene—Anaphylactic shock—Doxorubicin—uterine cancer	0.000437	0.000869	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.00043	0.000856	CcSEcCtD
Dantrolene—Thrombocytopenia—Doxorubicin—uterine cancer	0.000428	0.000851	CcSEcCtD
Dantrolene—Insomnia—Epirubicin—uterine cancer	0.000427	0.00085	CcSEcCtD
Dantrolene—Tachycardia—Doxorubicin—uterine cancer	0.000426	0.000848	CcSEcCtD
Dantrolene—Hyperhidrosis—Doxorubicin—uterine cancer	0.000422	0.00084	CcSEcCtD
Dantrolene—Somnolence—Epirubicin—uterine cancer	0.00042	0.000835	CcSEcCtD
Dantrolene—Anorexia—Doxorubicin—uterine cancer	0.000416	0.000829	CcSEcCtD
Dantrolene—Dyspepsia—Epirubicin—uterine cancer	0.000416	0.000827	CcSEcCtD
Dantrolene—Decreased appetite—Epirubicin—uterine cancer	0.00041	0.000817	CcSEcCtD
Dantrolene—Fatigue—Epirubicin—uterine cancer	0.000407	0.00081	CcSEcCtD
Dantrolene—Pain—Epirubicin—uterine cancer	0.000404	0.000803	CcSEcCtD
Dantrolene—Constipation—Epirubicin—uterine cancer	0.000404	0.000803	CcSEcCtD
Dantrolene—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000398	0.000792	CcSEcCtD
Dantrolene—Insomnia—Doxorubicin—uterine cancer	0.000395	0.000786	CcSEcCtD
Dantrolene—Feeling abnormal—Epirubicin—uterine cancer	0.000389	0.000774	CcSEcCtD
Dantrolene—Somnolence—Doxorubicin—uterine cancer	0.000388	0.000773	CcSEcCtD
Dantrolene—Gastrointestinal pain—Epirubicin—uterine cancer	0.000386	0.000768	CcSEcCtD
Dantrolene—Dyspepsia—Doxorubicin—uterine cancer	0.000385	0.000765	CcSEcCtD
Dantrolene—Decreased appetite—Doxorubicin—uterine cancer	0.00038	0.000756	CcSEcCtD
Dantrolene—Fatigue—Doxorubicin—uterine cancer	0.000377	0.000749	CcSEcCtD
Dantrolene—Urticaria—Epirubicin—uterine cancer	0.000375	0.000746	CcSEcCtD
Dantrolene—Pain—Doxorubicin—uterine cancer	0.000374	0.000743	CcSEcCtD
Dantrolene—Constipation—Doxorubicin—uterine cancer	0.000374	0.000743	CcSEcCtD
Dantrolene—Abdominal pain—Epirubicin—uterine cancer	0.000373	0.000743	CcSEcCtD
Dantrolene—Body temperature increased—Epirubicin—uterine cancer	0.000373	0.000743	CcSEcCtD
Dantrolene—Feeling abnormal—Doxorubicin—uterine cancer	0.00036	0.000716	CcSEcCtD
Dantrolene—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000357	0.000711	CcSEcCtD
Dantrolene—Hypersensitivity—Epirubicin—uterine cancer	0.000348	0.000692	CcSEcCtD
Dantrolene—Urticaria—Doxorubicin—uterine cancer	0.000347	0.000691	CcSEcCtD
Dantrolene—Abdominal pain—Doxorubicin—uterine cancer	0.000345	0.000687	CcSEcCtD
Dantrolene—Body temperature increased—Doxorubicin—uterine cancer	0.000345	0.000687	CcSEcCtD
Dantrolene—Asthenia—Epirubicin—uterine cancer	0.000339	0.000674	CcSEcCtD
Dantrolene—Pruritus—Epirubicin—uterine cancer	0.000334	0.000665	CcSEcCtD
Dantrolene—Diarrhoea—Epirubicin—uterine cancer	0.000323	0.000643	CcSEcCtD
Dantrolene—Hypersensitivity—Doxorubicin—uterine cancer	0.000322	0.00064	CcSEcCtD
Dantrolene—Asthenia—Doxorubicin—uterine cancer	0.000313	0.000624	CcSEcCtD
Dantrolene—Dizziness—Epirubicin—uterine cancer	0.000312	0.000621	CcSEcCtD
Dantrolene—Pruritus—Doxorubicin—uterine cancer	0.000309	0.000615	CcSEcCtD
Dantrolene—Vomiting—Epirubicin—uterine cancer	0.0003	0.000597	CcSEcCtD
Dantrolene—Diarrhoea—Doxorubicin—uterine cancer	0.000299	0.000595	CcSEcCtD
Dantrolene—Rash—Epirubicin—uterine cancer	0.000298	0.000592	CcSEcCtD
Dantrolene—Dermatitis—Epirubicin—uterine cancer	0.000297	0.000592	CcSEcCtD
Dantrolene—Headache—Epirubicin—uterine cancer	0.000296	0.000589	CcSEcCtD
Dantrolene—Dizziness—Doxorubicin—uterine cancer	0.000289	0.000575	CcSEcCtD
Dantrolene—Nausea—Epirubicin—uterine cancer	0.00028	0.000558	CcSEcCtD
Dantrolene—Vomiting—Doxorubicin—uterine cancer	0.000278	0.000553	CcSEcCtD
Dantrolene—Rash—Doxorubicin—uterine cancer	0.000275	0.000548	CcSEcCtD
Dantrolene—Dermatitis—Doxorubicin—uterine cancer	0.000275	0.000548	CcSEcCtD
Dantrolene—Headache—Doxorubicin—uterine cancer	0.000274	0.000545	CcSEcCtD
Dantrolene—Nausea—Doxorubicin—uterine cancer	0.000259	0.000516	CcSEcCtD
